Logo for Lipum

Lipum Investor Relations Material

Latest events

Logo for Lipum

Q2 2024

Lipum
Logo for Lipum

Q2 2024

9 Aug, 2024
Logo for Lipum

Q1 2024

28 May, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Lipum

Access all reports
Lipum AB, a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases. The company focuses on developing small molecule inhibitors of G protein-coupled receptors that regulate inflammation through modulation of intracellular trafficking pathways and other mechanisms. The company is based in Umeå, Sweden.